Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Stayble Therapeutics AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 34 More Arrow 160 Less Arrow 19
Earnings before taxes -8,065 Less Arrow -15,944 Less Arrow -16,389
EBITDA -8,213 Less Arrow -16,089 Less Arrow -16,570
Total assets 6,012 More Arrow 14,577 Less Arrow 12,795
Current assets 2,343 More Arrow 10,782 Less Arrow 9,020
Current liabilities 997 More Arrow 2,918 Less Arrow 2,015
Equity capital 4,463 More Arrow 11,088 Less Arrow 10,212
- share capital 3,692 Less Arrow 2,770 Less Arrow 1,203
Employees (average) 2 More Arrow 3 Equal arrow 3

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 74.2% More Arrow 76.1% More Arrow 79.8%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -133.6% More Arrow -108.3% Less Arrow -127.9%
Current ratio 235.0% More Arrow 369.5% More Arrow 447.6%
Return on equity (ROE) -180.7% More Arrow -143.8% Less Arrow -160.5%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -1 More Arrow 0 Equal arrow 0
Chg. No. of employees % -33% More Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.